Champions Oncology, Inc. announced that effective on or about January 31, 2017 Joel Ackerman, current CEO, will become Chairman of the Board of Directors and Dr. David Sidransky, the founder of the company and current Chairman of the Board of Directors, will assume the role of lead director. Dr. Ronnie Morris, current President of the company, will assume the role of CEO. In addition, Dr. Philip Breitfeld, a recent addition to the company's Board of Directors, will assume the position of Chief Strategic and Innovation Officer of the company.

Most recently he was Global Vice President at Quintiles, responsible for the Therapeutic Center of Excellence. This change is anticipated to occur during December 2016.